TY - CHAP
T1 - Human iPSC models of cardiac electrophysiology and arrhythmia
AU - Yang, Brenda
AU - Lowenthal, Justin
AU - Tomaselli, Gordon F.
AU - Tung, Leslie
N1 - Funding Information:
This work was supported by NIH grant R01-HL120959 (to LT), R01-HL128743 (to GFT), Maryland TEDCO grant 2016-MSCRFI-2735 (to GFT and LT), and AHA Predoctoral Fellowship 19PRE34381045 (to JL).
Funding Information:
The authors are grateful to the NIH National Heart, Lung, and Blood Institute, the Maryland TEDCO, and the American Heart Association for their support.
Publisher Copyright:
© 2022 Elsevier Inc. All rights reserved.
PY - 2022/1/19
Y1 - 2022/1/19
N2 - Cardiac arrhythmias and sudden cardiac death are a major cause of death worldwide. Defined as irregularities in heart rate or rhythm, arrhythmias can be caused by a variety of mechanisms, including abnormal automaticity, triggered activity, and reentry. Over the past decade, efforts allowing differentiation of cardiomyocytes from human induced pluripotent stem cells (hiPSC-CMs) derived from both healthy donors and those with cardiac disease have enabled invitro models of the human myocardium capable of recapitulating key functional, structural, and electrophysiological features of native tissue. Advances in these models have led to the generation of increasingly complex and physiologically relevant platforms, moving beyond the study of individual cells toward multidimensional networks of hiPSC-CMs that allow modeling of cardiac tissue as a functional syncytium. Though many hiPSC-derived myocardial models have been used to investigate cardiac electrophysiology and disease, few have explored the complex mechanisms of tissue-level arrhythmias and their contribution to myocardial pathogenesis. This chapter outlines existing single cell and multidimensional hiPSC-CM models of cardiac electrophysiology in the context of how they contribute to our understanding of tissue-level arrhythmia mechanisms in diseased states. We discuss not only the limitations but also the emerging uses of these models, and of hiPSC-CM technology more generally, in the context of modeling arrhythmia mechanisms. We also propose several design considerations for multicellular hiPSC-CM models so that they are better suited to investigate arrhythmogenic mechanisms on the tissue scale. We conclude with a brief discussion of broader relationships between tissue-level arrhythmias and other pathophysiologic mechanisms, such as metabolic disorders and inflammation.
AB - Cardiac arrhythmias and sudden cardiac death are a major cause of death worldwide. Defined as irregularities in heart rate or rhythm, arrhythmias can be caused by a variety of mechanisms, including abnormal automaticity, triggered activity, and reentry. Over the past decade, efforts allowing differentiation of cardiomyocytes from human induced pluripotent stem cells (hiPSC-CMs) derived from both healthy donors and those with cardiac disease have enabled invitro models of the human myocardium capable of recapitulating key functional, structural, and electrophysiological features of native tissue. Advances in these models have led to the generation of increasingly complex and physiologically relevant platforms, moving beyond the study of individual cells toward multidimensional networks of hiPSC-CMs that allow modeling of cardiac tissue as a functional syncytium. Though many hiPSC-derived myocardial models have been used to investigate cardiac electrophysiology and disease, few have explored the complex mechanisms of tissue-level arrhythmias and their contribution to myocardial pathogenesis. This chapter outlines existing single cell and multidimensional hiPSC-CM models of cardiac electrophysiology in the context of how they contribute to our understanding of tissue-level arrhythmia mechanisms in diseased states. We discuss not only the limitations but also the emerging uses of these models, and of hiPSC-CM technology more generally, in the context of modeling arrhythmia mechanisms. We also propose several design considerations for multicellular hiPSC-CM models so that they are better suited to investigate arrhythmogenic mechanisms on the tissue scale. We conclude with a brief discussion of broader relationships between tissue-level arrhythmias and other pathophysiologic mechanisms, such as metabolic disorders and inflammation.
KW - Abnormal automaticity
KW - Action potential
KW - Arrhythmia
KW - Cardiomyocyte
KW - Cardiomyopathy
KW - Channelopathy
KW - Delayed afterdepolarization
KW - Early afterdepolarization
KW - Electrophysiology
KW - Reentry
KW - Spiral wave
KW - Stem cell
KW - Tissue engineering
KW - Transmembrane voltage
KW - Triggered activity
UR - http://www.scopus.com/inward/record.url?scp=85128082899&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85128082899&partnerID=8YFLogxK
U2 - 10.1016/B978-0-323-85767-3.00006-2
DO - 10.1016/B978-0-323-85767-3.00006-2
M3 - Chapter
AN - SCOPUS:85128082899
SN - 9780323856454
SP - 29
EP - 93
BT - iPSCs - State of the Science
PB - Elsevier
ER -